ISRCTN87201238CompletedNot Applicable
Prophylactic sumatriptan for prevention of Acute Mountain Sickness: a double blind, randomised, placebo controlled, clinical trial
Imam Neurology Research Center (Iran)0 sites102 target enrollmentStarted: December 14, 2006Last updated:
Conditions
Trial Snapshot
- Phase
- Not Applicable
- Status
- Completed
- Sponsor
- Enrollment
- 102
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •1. Age of 18 to 60 years
- •2. Ascent to a high altitude of 3500 to 3900 metres above sea level from an altitude of at least 1500 metres
- •3. Consenting participant
- •4. May reasonably be expected to complete a 24 hour trial
Exclusion Criteria
- •1. Other neuro-vascular disease such as cerebrovascular accident, and hypoxic cerebral damage
- •2. Cardiovascular disease such as ischaemic heart disease, coronary artery disease, significant valvular disease, congestive heart failure, and uncontrolled hypertension with systolic pressure greater than 180 mmHg or diastolic pressure greater than 110 mmHg
- •3. Pregnancy
- •4. Hypersensitivity to either sumatriptan or acetazolamide or their components
Investigators
Similar Trials
Completed
Not Applicable
Prophylactic Gabapentin for Prevention of Acute Mountain Sickness: a double blind, randomised, placebo controlled, clinical trialInjury, Occupational Diseases, PoisoningMountain sicknessAcute mountain sicknessISRCTN26123577Tehran University of Medical Sciences (Iran)204
Active, not recruiting
Not Applicable
Aprepitant for prevention of acute and delayed nausea and vomiting: a phase III, double-blind, randomized, palcebo-controlled trial in patients receiving a high-emetogenic dose of cyclophosphamide for peripheral blood stem cells harvesting - NDEUCTR2009-017603-28-ITAZIENDA OSPEDALIERA DI PERUGIA
Not yet recruiting
Not Applicable
se of a drug (norepinephrine) for prevention of fall in BP in pregnant patients posted for delivery with operation during spinal anaesthesiaCTRI/2022/07/044398RNT Medical College and MB Hospital
Completed
Phase 4
A clinical trial of pregabalin for prevention of succinylcholine-induced fasciculation and myalgia (muscular pain)CTRI/2013/08/003925Apollo Hospitals Bilaspur60
Active, not recruiting
Phase 1
Study of antithrombin as prophylaxis of acute respiratory disease in patients with COVID-19EUCTR2020-001659-42-ESFundación para la Investigación Biomédica de Córdoba46